Stocks · News reference
Longeveron Alzheimer’s Therapy Shows Brain Inflammation Benefits, Presents New Alzheimer’s Stem Cell Therapy Data
Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that additional analysis of
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Longeveron shares are trading lower after the company announced a 1-for-10 reverse stock split.
Stock Market Today: Dow Jones, S&P 500, Nasdaq 1000 Futures Advance as Scott Bessent Expands Sanctions on Iran—NTS, GRRR, REAX, ZM, LGVN in Focus (UPDATED)
U.S. stock futures advanced on Tuesday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Monday's mixed close.
Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday
US stock futures mixed as investors focus on earnings from Dick's Sporting Goods, Trade Desk, Intuit, Longeveron, and Zoom Communications.